PPT-Respecting the Burden of Adherence
Author : stefany-barnette | Published Date : 2018-10-29
Ronni AW Wetmore RN MS Coordinator Stanford Adult Cystic Fibrosis Center Speaker Bureau Chiesi Pharmaceuticals Nurse Advisory Board Genentech Pharmaceutical Company
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Respecting the Burden of Adherence" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Respecting the Burden of Adherence: Transcript
Ronni AW Wetmore RN MS Coordinator Stanford Adult Cystic Fibrosis Center Speaker Bureau Chiesi Pharmaceuticals Nurse Advisory Board Genentech Pharmaceutical Company Nurse Advisory Board Gilead Pharmaceutical. Doyle M. Cummings, PharmD, FCP, FCCP. Professor of Family Medicine and Public Health. East Carolina University, Brody School of Medicine. Greenville, North Carolina. . [Residency educators may . adapt and use . www.YourDiabetesInfo.org/MedicationAdherence. . Medication Adherence: Resources for Patients. Medication Adherence: Resources for Health Care Teams. Medication Adherence: Scientific Evidence. Criteria For Inclusion. Meck Chongo, . Virginia . Russell, . Josée. Lavoie, Ross Hoffman, . Mamdouh. . Shubair. University of Northern British Columbia. Agenda. . Background. Objectives . Participants & Research Environment. Bernard Vrijens, PhD. Chief Science Officer, MWV Healthcare. Associate Professor of Biostatistics . University of Liège, Belgium. Adherence is key to therapeutic success. 2. Effective. Disease. Management. Ronni. AW Wetmore, RN, MS. Coordinator, Stanford Adult Cystic Fibrosis Center. Speaker Bureau: . Chiesi. Pharmaceuticals. Nurse Advisory Board: Genentech Pharmaceutical Company. Nurse Advisory Board: Gilead Pharmaceutical. Lessons from a 3-month Placebo Gel Trial at 3 US sites. Alex Carballo-Diéguez, Ph.D. .. Columbia University, NYC, US. Background. In the USA, young men who have sex with men (YMSM), especially those who are ethnic minorities, have high prevalence and incidence of HIV. Angelica Lindsey-Ali & Calicia White. Ebony House Inc.. Objectives. By the end of this section, participants should be able to. : . Understand the difference between cultural humility and cultural competence. Patients do . not. take their medicine . as prescribed. about . half. the time. . 2. Why is it important to assess adherence?. =. 3. 4. Eight. . steps to . improve medication adherence. in . your. Simi Padival, MD. November 3, 2016. Objectives. Learn about the importance of assessing adherence to antiretroviral therapy (ART). Learn about the components of assessing for ART adherence. Discuss frequency of monitoring while on ART. Adherence vs. Compliance . Adherence. : “the degree to which a person’s behavior coincides with medical advice”. Adherence requires the patient’s agreement with the recommendations. Compliance. Patients do . not. take their medicine . as prescribed. about . half. the time. . 2. Why is it important to assess adherence?. =. 3. 4. Eight. . steps to . improve medication adherence. in . your. Dr. Seema Sahay, Ph.D. Division of Social and Behavioral Research. National AIDS Research Institute. Indian Council of Medical Research, Pune (India). Overview. Defining and measuring adherence. Issues around adherence. Ira Wilson, MD, . MSc. 1. Conflicts of Interest. Dr. Wilson has no conflicts . of interest. 2. Goals: 4 Questions. Is provider-patient. communication really that important in adherence?. What is the quality of adherence related communication?. EPF Position Paper March 2015 2 Adherence and Concordance EPF position paper , March 2015 Contents 1 Introduction ................................ ................................ ....................
Download Document
Here is the link to download the presentation.
"Respecting the Burden of Adherence"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents